Bayview Pharmacy is pleased to present a unique topical gel formulation of Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05%. This innovative combination of medications is designed to address a range of skin conditions, including rosacea, acne, and seborrheic dermatitis.

The formulation is a semisolid compound dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients, providing effective relief from the symptoms of these skin conditions.

Ivermectin, the first active ingredient, is an anti-parasitic medication that works by eliminating certain types of parasites. It is particularly effective in treating rosacea, acne, and seborrheic dermatitis by reducing inflammation and killing bacteria that may contribute to these conditions.

Brimonidine Tartrate, the second active ingredient, is a vasoconstrictor that aids in reducing redness and inflammation. It works by narrowing the blood vessels in the skin, thereby reducing the appearance of redness and inflammation associated with these skin conditions.

Ketotifen, the third active ingredient, is an antihistamine that helps alleviate itching and inflammation. It works by blocking the release of substances in the body that cause inflammation and itching, providing relief from these symptoms.

This unique combination of Ivermectin, Brimonidine Tartrate, and Ketotifen in a topical gel formulation offers an effective treatment for rosacea, acne, and seborrheic dermatitis. It is designed to reduce inflammation, redness, and itching associated with these conditions, providing relief and improving the appearance of the skin. Furthermore, this formulation is safe and well-tolerated, with minimal side effects.

If you have any questions about this formulation or how it can help treat your skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most effective treatment for your specific needs.

This compounded formulation of Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, ensuring targeted treatment or absorption of active ingredients in a gel-like consistency. This formulation is primarily used for the treatment of various skin conditions such as rosacea, acne, and seborrheic dermatitis. It also proves effective in treating scabies and other parasitic infestations.

The active ingredients in this formulation work synergistically to alleviate symptoms and treat the underlying causes of these skin conditions. Ivermectin, an anti-parasitic medication, functions by eliminating the parasites that cause skin conditions. Brimonidine Tartrate, an alpha-2 agonist, reduces redness and inflammation. Ketotifen, an antihistamine, blocks the release of histamine, thereby reducing itching and inflammation.

Generally, this formulation is well tolerated by most patients. However, some may experience mild side effects such as skin irritation, burning, and stinging. It is recommended that patients avoid contact with the eyes and use sunscreen while using this product. Additionally, patients should refrain from using other topical medications concurrently with this product to minimize the risk of skin irritation.

For any further queries or concerns regarding this formulation or its usage, please feel free to reach out. It is always advisable to consult with a healthcare professional before starting any new medication regimen.

Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05% Topical Gel is a compounded medication designed to treat a range of skin conditions. This unique formulation combines three active ingredients: ivermectin, an anti-parasitic medication; brimonidine tartrate, a vasoconstrictor; and ketotifen, an antihistamine. Together, these ingredients work synergistically to alleviate inflammation, itching, and redness associated with various skin conditions.

Ivermectin functions by eliminating parasites that can cause skin conditions such as scabies and lice. Brimonidine tartrate operates by constricting the blood vessels in the skin, thereby reducing redness and inflammation. Ketotifen, on the other hand, works by inhibiting the release of histamine, a substance that can trigger itching and inflammation.

The Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the medication ensures it adheres well to the skin, maximizing its therapeutic effects.

Typically, this topical gel is applied directly to the affected area of the skin once or twice daily, depending on the severity of the condition. It is crucial to adhere to the instructions provided by your healthcare provider or pharmacist when using this medication.

This compounded formulation is used to treat a variety of skin conditions, including but not limited to scabies, lice, eczema, psoriasis, and contact dermatitis. It can also be effective in treating rosacea and other inflammatory skin conditions. As with any medication, it is important to consult with a healthcare professional to determine if this treatment is right for you.

If you have any questions about Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05% Topical Gel or its mechanism of action, please do not hesitate to reach out. We are here to assist you in finding the most suitable treatment for your skin condition.

This compounded formulation of Ivermectin 1%/Brimonidine Tartrate 0.5%/Ketotifen 0.05% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation aids in its smooth application and absorption.

The formulation has been found to be effective in treating a range of skin conditions including Demodex Folliculorum, Rosacea, Seborrheic Dermatitis, Acne Vulgaris, and Perioral Dermatitis. It is crucial to understand that this formulation is not intended to treat any other skin conditions, as its efficacy for other conditions has not been tested. Therefore, it should not be used for any other skin conditions without the advice of a healthcare provider.

It is also important to note that this formulation should not be used in conjunction with other topical medications. Doing so may increase the risk of adverse effects. Some potential side effects of this formulation include skin irritation, redness, or burning. If any of these side effects occur, it is recommended to discontinue use and contact a healthcare provider immediately.

Furthermore, this formulation may cause temporary blurred vision. As such, patients are advised not to drive or operate machinery until their vision has returned to normal. If you have any questions or concerns about the use of this formulation, it is recommended to consult with a healthcare provider.